Safety, Tolerance and Antiretroviral Activity of Dasatinib: a Pilot Clinical Trial in Patients With Recent HIV-1 Infection
Condition(s):Recent HIV-1 InfectionLast Updated:March 6, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Recent HIV-1 InfectionLast Updated:March 6, 2024Recruiting
Condition(s):Precursor Cell Lymphoblastic Leukemia-Lymphoma; Philadelphia-Positive Acute Lymphoblastic Leukemia; ALL, AdultLast Updated:October 1, 2021Unknown status
Condition(s):AgingLast Updated:August 3, 2021Unknown status
Condition(s):HIV Infection PrimaryLast Updated:December 15, 2023Recruiting
Condition(s):Leukemia, Lymphoblastic, Acute, Philadelphia-PositiveLast Updated:March 17, 2022Completed
Condition(s):Chronic Phase Chronic Myeloid LeukemiaLast Updated:November 22, 2016Completed
Condition(s):Chronic Myelogenous LeukemiaLast Updated:September 22, 2023Completed
Condition(s):Chronic Myeloid Leukemia, Chronic PhaseLast Updated:December 6, 2022Recruiting
Condition(s):Head and Neck CancerLast Updated:January 9, 2019Terminated
Condition(s):Non-Hodgkin’s Lymphoma; Hodgkin’s Lymphoma; Myeloid Leukemia; Multiple Myeloma; Myelodysplastic Syndrome; Lymphoid LeukemiaLast Updated:December 17, 2020Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.